XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS PER COMMON SHARE
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2025 and 2024 (in thousands, except share and per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Numerator
Net income attributable to Sabra Health Care REIT, Inc.$22,538 $29,788 $128,384 $80,017 
Denominator
Basic weighted average common shares and common equivalents239,896,059 234,290,187 238,595,147 232,459,388 
Dilutive restricted stock units2,858,700 2,505,456 2,678,599 2,236,433 
Dilutive forward equity sale agreements803,690 247,757 320,246 81,280 
Diluted weighted average common shares243,558,449 237,043,400 241,593,992 234,777,101 
Net income attributable to Sabra Health Care REIT, Inc., per:
Basic common share$0.09 $0.13 $0.54 $0.34 
Diluted common share$0.09 $0.13 $0.53 $0.34 
During the nine months ended September 30, 2025, approximately 600 restricted stock units and 24,300 shares related to forward equity sale agreements were not included in computing diluted earnings per share because they were considered anti-dilutive. During the three and nine months ended September 30, 2024, approximately 10,000 shares and 5,200 shares, respectively, related to forward equity sale agreements were not included in computing diluted earnings per share because they were considered anti-dilutive. Additionally, during the nine months ended September 30, 2024, approximately 800 restricted stock units were not included in computing diluted earnings per share because they were considered anti-dilutive.